Fludrocortisone acetate 0.1 MG Oral Tablet — RxCUI 313979
RxNorm drug concept · Semantic clinical drug
RxCUI 313979
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313979
Official nameFludrocortisone acetate 0.1 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped16
Package NDCs mapped26
Reported Medicaid activity (SDUD)163,495 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fludrocortisone Acetate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Fludrocortisone Acetate tablets help replace adrenal hormone activity in Addison's disease. They are also used for salt-losing adrenogenital syndrome. It helps your body keep the r...
- You take it by mouth, usually once a day, though your doctor sets the schedule. In Addison's disease it is often taken with hydrocortisone or cortisone. Follow your prescriber's di...
- Most come from salt and water retention, such as higher blood pressure, swelling and weight gain. Low potassium can cause muscle weakness. Call your doctor if you notice these, sin...
- Yes, regular checks of blood pressure and blood electrolytes (salts like potassium) are advised. Your doctor may also suggest less salt or a potassium supplement. Keep your appoint...
🕸️ Concept Web — How Fludrocortisone acetate 0.1 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fludrocortisone acetate 0.1 MG Oral Tablet
RxCUI 313979 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Fludrocortisone
4452IN -
Fludrocortisone acetate
165516PIN
-
Fludrocortisone
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fludrocortisone Oral Tablet
372213SCDF -
Fludrocortisone acetate Oral Tablet
2649026SCDFP -
Fludrocortisone Oral Product
1160242SCDG -
Fludrocortisone Pill
1160243SCDG -
Fludrocortisone acetate Oral Product
2661323SCDGP -
Fludrocortisone acetate Pill
2662430SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Fludrocortisone Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fludrocortisone acetate 0.1 MG
2388622SCDC
-
Fludrocortisone acetate 0.1 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fludrocortisone acetate 0.1 MG
SCDC · 2388622 -
Fludrocortisone Oral Tablet
SCDF · 372213 -
Fludrocortisone acetate Oral Tablet
SCDFP · 2649026 -
Fludrocortisone Oral Product
SCDG · 1160242 -
Fludrocortisone Pill
SCDG · 1160243 -
Fludrocortisone acetate Oral Product
SCDGP · 2661323 -
Fludrocortisone acetate Pill
SCDGP · 2662430
📦 FDA Products & Package NDCs
16 products · 26 package NDCs
26 package NDCs map to RxCUI 313979 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00115-7033-01 | 100 TABLET in 1 BOTTLE (0115-7033-01) | Fludrocortisone Acetate | Amneal Pharmaceuticals of New York LLC | 2002-03-18 |
| 00115-7033-02 | 500 TABLET in 1 BOTTLE (0115-7033-02) | Fludrocortisone Acetate | Amneal Pharmaceuticals of New York LLC | 2002-03-18 |
| 00115-7033-03 | 1000 TABLET in 1 BOTTLE (0115-7033-03) | Fludrocortisone Acetate | Amneal Pharmaceuticals of New York LLC | 2002-03-18 |
| 00615-6562-39 | 30 TABLET in 1 BLISTER PACK (0615-6562-39) | Fludrocortisone Acetate | NCS HealthCare of KY, LLC dba Vangard Labs | 2020-10-07 |
| 00904-7317-06 | 50 BLISTER PACK in 1 CARTON (0904-7317-06) / 1 TABLET in 1... | Fludrocortisone Acetate | Major Pharmaceuticals | 2024-09-04 |
| 00904-7317-61 | 100 BLISTER PACK in 1 CARTON (0904-7317-61) / 1 TABLET in 1... | Fludrocortisone Acetate | Major Pharmaceuticals | 2024-09-04 |
| 42291-0764-01 | 100 TABLET in 1 BOTTLE (42291-764-01) | Fludrocortisone Acetate | AvKARE | 2021-01-13 |
| 50268-0330-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-330-15) / 1 TABL... | FLUDROCORTISONE ACETATE | AvPAK | 2011-08-01 |
| 51407-0705-01 | 100 TABLET in 1 BOTTLE (51407-705-01) | Fludrocortisone acetate | Golden State Medical Supply, Inc. | 2025-06-10 |
| 55154-2644-00 | 10 BLISTER PACK in 1 BAG (55154-2644-0) / 1 TABLET in 1 BLI... | Fludrocortisone Acetate | Cardinal Health 107, LLC | 2025-02-25 |
| 55154-6645-00 | 10 BLISTER PACK in 1 BAG (55154-6645-0) / 1 TABLET in 1 BLI... | Fludrocortisone Acetate | Cardinal Health 107, LLC | 2008-05-09 |
| 68084-0288-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-288-01) / 1 TAB... | Fludrocortisone Acetate | American Health Packaging | 2008-09-05 |
| 68084-0288-65 | 50 BLISTER PACK in 1 CARTON (68084-288-65) / 1 TABLET in 1... | Fludrocortisone Acetate | American Health Packaging | 2023-02-09 |
| 69238-7033-01 | 100 TABLET in 1 BOTTLE (69238-7033-1) | Fludrocortisone Acetate | Amneal Pharmaceuticals NY LLC | 2002-03-18 |
| 69238-7033-05 | 500 TABLET in 1 BOTTLE (69238-7033-5) | Fludrocortisone Acetate | Amneal Pharmaceuticals NY LLC | 2002-03-18 |
| 70771-1893-01 | 100 TABLET in 1 BOTTLE (70771-1893-1) | Fludrocortisone acetate | Zydus Lifesciences Limited | 2024-12-02 |
| 70771-1893-05 | 500 TABLET in 1 BOTTLE (70771-1893-5) | Fludrocortisone acetate | Zydus Lifesciences Limited | 2024-12-02 |
| 70954-0252-10 | 30 TABLET in 1 BOTTLE (70954-252-10) | Fludrocortisone Acetate | Novitium Pharma LLC | 2022-06-02 |
| 70954-0252-20 | 100 TABLET in 1 BOTTLE (70954-252-20) | Fludrocortisone Acetate | Novitium Pharma LLC | 2022-06-02 |
| 70954-0252-30 | 500 TABLET in 1 BOTTLE (70954-252-30) | Fludrocortisone Acetate | Novitium Pharma LLC | 2022-06-02 |
| 71335-2454-01 | 100 TABLET in 1 BOTTLE (71335-2454-1) | Fludrocortisone Acetate | Bryant Ranch Prepack | 2024-07-30 |
| 71930-0088-12 | 100 TABLET in 1 BOTTLE (71930-088-12) | fludrocortisone acetate | Eywa Pharma Inc | 2025-06-02 |
| 71930-0088-52 | 500 TABLET in 1 BOTTLE (71930-088-52) | fludrocortisone acetate | Eywa Pharma Inc | 2025-06-02 |
| 72578-0164-01 | 100 TABLET in 1 BOTTLE (72578-164-01) | Fludrocortisone acetate | Viona Pharmaceuticals Inc | 2024-12-02 |
| 72578-0164-05 | 500 TABLET in 1 BOTTLE (72578-164-05) | Fludrocortisone acetate | Viona Pharmaceuticals Inc | 2024-12-02 |
| 72603-0170-01 | 100 TABLET in 1 BOTTLE (72603-170-01) | Fludrocortisone Acetate | NorthStar Rx LLC | 2023-09-07 |
Observed labelers:
Amneal Pharmaceuticals of New York LLC (3) ·
Novitium Pharma LLC (3) ·
American Health Packaging (2) ·
Amneal Pharmaceuticals NY LLC (2) ·
Cardinal Health 107, LLC (2) ·
Eywa Pharma Inc (2)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.3206
Range $0.3206–$0.3206
· middle 50% $0.3206–$0.3206
· 14 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.